List view / Grid view

Alex Zhavoronkov – Founder and CEO of Insilico Medicine

 

news

First AI-designed drug, Rentosertib, officially named by USAN

Insilico Medicine’s AI-designed drug for idiopathic pulmonary fibrosis (IPF), Rentosertib,…

14 March 2025 | By

Insilico Medicine’s AI-designed drug for idiopathic pulmonary fibrosis (IPF), Rentosertib, has been granted an official name by USAN. This is the first drug where both the target and compound were discovered using generative AI, marking a major milestone in AI-driven drug development.